*Speculative* $DARE - Long to $2-$3

Zaktualizowano
Women's healthcare company - Lots of upcoming catalysts through 2020. New acquisition this week of Microchips. Could see this fall to .50s if earnings are garbage - which is definitely a possibility, but target is still $2-$3 next year. This is speculative, but I will hold 5k shares from .79 avg.
Uwaga
Achieved price target on Bayer licensing deal new this morning. Reduced from 5k shares to 2k. .79 to 2.05 - for $3750 profit. DARE
Uwaga
Reduced further to 500 shares. Could go higher, but history shows this likes to pop and drop. Also, probably a good time for them to do an offering on this news, so I don't want push my luck.
Uwaga
Adding to current position. Going to leg in here slowly, starting with 2500 shares. 1.15 avg
Beyond Technical AnalysisbiotechbiotechnologyChart PatternsDAREhealthcareTechnical Indicatorswomen

Również na:

Wyłączenie odpowiedzialności